Search for: "In re: Effexor XR Antitrust" Results 1 - 9 of 9
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
In re Effexor XR Antitrust Litigation: FTC Amicus Argues for No-Authorized-Generic in Patent Settlements
16 Aug 2013, 9:57 am by Federal Trade Commission
The FTC’s amicus brief states that the Effexor XR case presents “an issue with significant implications for American consumers”: whether pharmaceutical patent settlements are “immune from antitrust scrutiny so long as the brand-name drug manufacturer pays for delayed entry with something other than cash. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
In re Effexor XR Antitrust Litigation: FTC Amicus Argues for No-Authorized-Generic in Patent Settlements
16 Aug 2013, 9:57 am by Federal Trade Commission
The FTC’s amicus brief states that the Effexor XR case presents “an issue with significant implications for American consumers”: whether pharmaceutical patent settlements are “immune from antitrust scrutiny so long... [read post]
IPWatchdog - http://www.ipwatchdog.com/
District of New Jersey Stays Pay-For-Delay Cases Pending High Court's Decision in K-Dur
25 Oct 2012, 7:22 am by Christopher Walsh
Defendants in reverse-payment actions pending in the Third Circuit (New Jersey, Pennsylvania, and Delaware) take note: in In re Effexor XR Antitrust Litigation the Honorable Joel A. [read post]
IP Law Alert - http://www.iplawalert.com
FTC Files Amicus Brief in Antitrust Suit to Challenge “Pay-for-Delay” Generic Drug Deal
14 Aug 2012, 8:50 pm
This posting was written by Cheryl Beise, Contributor to IP Law Daily.The Federal Trade Commission announced yesterday that it has filed an Amicus Brief with the federal district court in Trenton, New Jersey in the Effexor XR Antitrust Litigation to challenge an agreement between Wyeth and Teva Pharmaceuticals as an illegal restraint of trade. [read post]
Trade Regulation Talk - http://traderegulation.blogspot.com/
FTC Files Amicus Brief in Antitrust Suit to Challenge “Pay-for-Delay” Generic Drug Deal
14 Aug 2012, 8:50 pm
This posting was written by Cheryl Beise, Contributor to IP Law Daily.The Federal Trade Commission announced yesterday that it has filed an Amicus Brief with the federal district court in Trenton, New Jersey in the Effexor XR Antitrust Litigation to challenge an agreement between Wyeth and Teva Pharmaceuticals as an illegal restraint of trade. [read post]
Trade Regulation Talk - http://traderegulation.blogspot.com/
FTC Files Amicus Brief in Antitrust Suit to Challenge “Pay-for-Delay” Generic Drug Deal
14 Aug 2012, 8:50 pm
This posting was written by Cheryl Beise, Contributor to IP Law Daily.The Federal Trade Commission announced yesterday that it has filed an Amicus Brief with the federal district court in Trenton, New Jersey in the Effexor XR Antitrust Litigation to challenge an agreement between Wyeth and Teva Pharmaceuticals as an illegal restraint of trade. [read post]
Trade Regulation Talk - http://traderegulation.blogspot.com/
Big Pharma Faces More Pay-for-Delay Fallout
27 Aug 2017, 10:01 pm by Barry Barnett
Supp. 3d 523 (D.N.J. 2014); In re Effexor XR Antitrust Litig., No. [read post]
The Contingency - http://www.thecontingency.com
Big Pharma Faces More Pay-for-Delay Fallout
27 Aug 2017, 10:01 pm by Barry Barnett
Supp. 3d 523 (D.N.J. 2014); In re Effexor XR Antitrust Litig., No. [read post]
The Contingency - http://www.thecontingency.com
Hot Ticket Item – Patent Settlement Agreement Challenges
29 Aug 2012, 10:09 pm by FDABlog HPM
EFFEXOR XR. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/